Loading data
DOCNNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 901.43 m USD | 780.62 m USD | 692.88 m USD | 576.32 m USD | 428.56 m USD |
| Cost of revenue | 361.84 m USD | 314.67 m USD | 295.39 m USD | 211.93 m USD | 170.6 m USD |
| Gross profit | 539.59 m USD | 465.94 m USD | 397.5 m USD | 364.4 m USD | 257.97 m USD |
| Research and development expense | 161.62 m USD | 142.5 m USD | 136.92 m USD | 143.89 m USD | 115.68 m USD |
| Operating profit | 156.99 m USD | 91.01 m USD | 11.9 m USD | -25.7 m USD | -11.19 m USD |
| Interest expense | — | — | 8.95 m USD | 8.4 m USD | 3.74 m USD |
| Profit before tax | 206.66 m USD | 97.7 m USD | 26.78 m USD | -23.89 m USD | -18.2 m USD |
| Income tax expense | -52.6 m USD | 13.21 m USD | 7.37 m USD | 3.92 m USD | 1.3 m USD |
| Net income (reported basis) | 259.26 m USD | 84.49 m USD | 19.41 m USD | -27.8 m USD | -19.5 m USD |
| Net income attributable to common shareholders | 259.26 m USD | 84.49 m USD | 19.41 m USD | -27.8 m USD | -19.5 m USD |
| Basic earnings per share | 2.83 USD/share | 0.92 USD/share | 0.22 USD/share | -0.28 USD/share | -0.21 USD/share |
| Diluted earnings per share | 2.52 USD/share | 0.89 USD/share | 0.2 USD/share | -0.28 USD/share | -0.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.